High-Growth, Tech-Driven Health Logistics and Pharmaceutical Distributor

A leading, long-established pharmaceutical distributor is raising $36.4 million USD to fund its transformation into a national health logistics platform—powered by proprietary SaaS and AI systems, and backed by over $45.5 million USD in independently appraised real estate.

With 24 years of uninterrupted profitability, secured government contracts, and a fully developed franchise rollout strategy, this business offers a rare combination of scale, stability, and future upside.

Key Investment Highlights

·        21.03% Equity Available — Based on a $173 million USD post-money valuation

·        Convertible Note Option — 3–4 year maturity, 6–8% coupon, 15–20% discount to future raise

·        Real Estate Collateral — Appraised at $45.5 million USD

·        Signed $4.9M USD Government Contract — Active and revenue-generating

·        SaaS + AI Rollout — Fully costed and led by an Australian advisory firm

·        Franchise Expansion Model — 100+ stores, $1.82M+ USD in recurring royalties projected

·        Exit Pathways — IPO or M&A planned within 3–5 years